(Press-News.org) PLYMOUTH MEETING, PA [March 1, 2023] — The National Comprehensive Cancer Network® (NCCN®) today announced the NCCN 2023 Annual Conference will debut a new hybrid format, including in-person events at a new venue. This marks the first time in three years that this premier oncology meeting will be held in-person, and the first-ever time at the Orlando World Center Marriott, starting on March 31.
“We’ve heard from many people who learn better by being in the ‘room where it happens,’” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “This format allows for a different kind of focus, makes it easier to ask questions, and provides space for the types of hallway conversations that advance networking and education. At the same time, we are building on our experience with virtual events over the past few years and applying it to keep this conference accessible to everybody everywhere.”
The NCCN Annual Conference is held every year to ensure members of interprofessional oncology care teams—including physicians, nurse practitioners, nurses, physician associates, pharmacists, and other relevant health care professionals—have the knowledge and skills necessary to apply the latest standards of oncology care and stay current on recent updates. More than 30 educational sessions will provide information to help attendees review new, emerging, and novel therapeutic agents, treatment strategies, and clinical trials data, and apply these findings to improve patient care. Plenary sessions will address important and timely issues affecting delivery of oncology care to patients with cancer and cancer survivors, including addressing unique needs of LGBTQ+ people with cancer, retaining high-value staff during the current landscape, and reducing the toll from cancer treatment-related fatigue and other quality-of-life issues.
“The emergence of new biomarkers and advances in molecular profiling, imaging and radiation techniques, surgical procedures, and new immunotherapeutic agents and other drugs is rapidly changing the oncology landscape, making it more complex than ever, but providing patients and providers with expanded options,” said Wui-Jin Koh, MD, Senior Vice President, Chief Medical Officer, NCCN. “We’re happy to provide this opportunity to learn about the evidence that underpins any updates to the NCCN Guidelines, and the chance to interact directly with the experts responsible for those recommendations. Attendees can return to their patients knowing they are up to date on the latest management strategies to help patients achieve the best possible outcomes.”
The NCCN 2023 Annual Conference will also feature more than 100 abstract poster presentations featuring original research data in a variety of oncology-related categories, including:
Best Practices in Implementation and Use of Clinical Practice Guidelines
Bioinformatics/Information Technology Sciences
Clinical and Pre-Clinical Oncology
Correlative/Genomic
Epidemiology/Risks/Prevention
Outcomes and Health Services
Quality Improvement
The posters include topics such as CAR T, Stem Cell Transplantation, Treatment Utilization Trends, Opioid Prescribing Trends, e-Cigarettes, Disparities, and the ongoing impact of COVID-19.
“The poster session presented by the NCCN Oncology Research Program is outstanding this year, both in terms of the rigor of the research being presented, and the meaningful impact it will have on patients’ lives,” said Crystal S. Denlinger, MD, FACP, Senior Vice President, Chief Scientific Officer, NCCN. “I’m excited to hear these investigators dig even deeper into their findings during the oral poster presentations and the in-person poster presentations.”
There are several events planned to enhance the in-person experience, including a new “Follow the Experts” guided tour through dozens of poster abstracts showcasing cutting-edge research on cancer treatment and delivery. New “Continue the Conversation” sessions will provide small group settings where in-person attendees can directly connect with the speakers themselves for more informal discussions about topics presented during the conference. The opening night reception is one of many opportunities for networking in a relaxed, engaging environment. A live exhibit hall includes information on patient advocacy and reimbursement, along with special showcase presentations. All in-person attendees will also have full access to the virtual platform.
Physicians, nurses, pharmacists, physician associates, and case managers who complete these sessions in-person or online are eligible for continuing education credits through various accreditation agencies.
Visit NCCN.org/conference to view the full agenda and register. There is also more information about the NCCN 2023 Nursing Program: Advancing Oncology Nursing, NCCN 2023 Fellows Program: New Horizons in Quality Cancer Care, and the NCCN Academy For Excellence and Leadership in Oncology, all taking place on March 30, 2023 for unique audiences in conjunction with the conference.
# # #
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
END
One of the biggest potential single sources of carbon emissions from wooded parts of Norway has four legs, weighs as much as 400-550 kg and has antlers.
That’s right — moose can reduce carbon storage in clearcut sites equivalent to as much as 60 per cent of the annual fossil fuel carbon emissions from a region, a new study shows.
“Moose are an ecosystem engineer in the forest ecosystem, and strongly impact everything from the species composition and nutrient availability in the forest,” said Gunnar Austrheim, an ecologist at the NTNU University Museum who was one of the study’s co-authors. “A grown animal can eat 50 kilograms ...
A new Florida Atlantic University study on America’s urban travel trends shows important variations in travel behaviors across income, home ownership, ethnicity, gender, age, and life-cycle stages. The sixth in a series of studies compared changes in travel modes, trip frequency, trip distance and vehicle ownership among a range of socioeconomic groups using nationwide travel survey data since 1977.
The most notable trend, published in the journal Transportation Research Part D, reveals that although private automobiles continue to be the dominant travel mode in American cities, the share of car trips has slightly and steadily decreased ...
Chicago, March 1, 2023 — Sharon K. Inouye, M.D., M.P.H., Professor of Medicine at Harvard Medical School and the Milton and Shirley F. Levy Family Chair and Director of the Aging Brain Center, Marcus Institute for Aging Research at Hebrew SeniorLife has been named the editor in chief of JAMA Internal Medicine.
An internationally recognized leader in internal medicine, geriatrics, and aging research, Dr. Inouye’s research focuses on delirium and functional decline in hospitalized older patients. She is currently the overall principal investigator of the Successful Aging after ...
Chemotherapy affects the ability of a patient’s immune system to attack pancreatic tumors, a new study shows.
Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the work revolves around the immune system, which includes T cells designed to attack foreign organisms like viruses. To spare normal cells, the system uses “checkpoint” molecules like PD1 on T cell surfaces to turn off their attack when they receive the right signals. The body also recognizes tumors as abnormal, but cancer cells ...
Transgender men can, and often wish to, become pregnant. However, they do need extra guidance and care providers often lack the necessary knowledge and skills. Amsterdam UMC is the first to conduct qualitative research into the experiences of Dutch transgender people with maternity care. This research is now avaliable as a pre-print in Midwifery.
Transgender men often undergo medical procedures to adjust their bodies to their male gender identity. These medical interventions can affect fertility. Some transgender men therefore choose not to undergo these treatments, postpone them or, even, to temporarily stop them. ...
A study just published in the American Journal of Clinical Nutrition (AJCN) explored the role of omega-3 fatty acids, especially EPA and DHA, and whether they might be protective against contracting and/or suffering adverse outcomes of COVID-19 infection.
The study compared the risk for three COVID-19 outcomes: 1-testing positive, 2-hospitalization, and 3-death as a function of baseline plasma DHA levels.
DHA levels (% of total fatty acids) were measured by Nuclear Magnetic Resonance (NMR) spectroscopy but were converted to Omega-3 Index (red blood ...
Certain diseases, including Alzheimer’s, are currently considered “undruggable” because traditional small molecule drugs can’t interfere with the proteins responsible for the illnesses. But a new technique that specifically targets and breaks apart certain proteins — rather than just interfering with them — may offer a pathway toward treatment. Researchers reporting in ACS Central Science have, for the first time, designed a compound that targets and breaks down a posttranslationally modified protein closely associated with Alzheimer’s disease.
Researchers have been exploring targeted protein degradation (TPD) as a way to get at ...
Wastewater can provide clues about a community’s infectious disease status, and even its prescription and illicit drug use. But looking at sewage also provides information on persistent and potentially harmful compounds, such as per- and polyfluoroalkyl substances (PFAS), that get released into the environment. Now, researchers in ACS’ Environmental Science & Technology Letters report an unexpected source of these substances in wastewater systems — toilet paper.
PFAS have been detected in many personal care products, such as cosmetics and cleansers, that people use every day and then wash down ...
PULLMAN, Wash – Glacier National Park is home to around 50 Canada lynx, more than expected, surprising scientists who recently conducted the first parkwide occupancy survey for the North American cat.
The Washington State University-led survey reveals the iconic predator resides across most of Glacier’s 1,600 square-mile landscape, although at lower densities than in the core of its range further north.
“The population in the park is still substantial and exceeded our expectations,” said Dan Thornton, WSU wildlife ecologist ...
The United States Patent and Trademark Office has awarded Fraunhofer USA with a patent for algorithms that detect and quantify air leakage from single-family homes using data from commercially available communicating, thermostats.
Outdoor air can infiltrate homes through many pathways, including windows and doors, poorly sealed connections between exterior walls and basements and attics, and unsealed wall, floor, and ceiling penetrations in occupied spaces. Prior field studies have found that most homes have appreciable air leakage, which accounts for approximately a quarter of space conditioning energy consumption. Not only can air leakage significantly increase home energy consumption, ...
